NIH-funded research NIH-funded research

CSE and hydrogen sulfide: new clues about aging and blood vessels

Official title: Cystathionine Gamma Lyase (CSE) and Hydrogen Sulfide Regulation of Vascular Aging

Funded at Louisiana State Univ Hsc Shreveport · NIH-11379113 · Data updated 2026-11-12

A doctor-scientist at LSU Health Shreveport is studying how a molecule called CSE and hydrogen sulfide affect aging blood vessels and heart-related health.

More Aging research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLouisiana State Univ Hsc Shreveport
NIH-funded
Lab location1 site (Shreveport, United States)
Project startFebruary 1, 2018
Project endJune 30, 2028
Funding year2026
Award (this year)$196,585
NIH project number5P20GM121307-09
Project IDNIH-11379113 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be individuals affected by age-related vascular issues or those with conditions linked to aging and vascular aging, who may contribute samples or participate in future studies.

Less likely to help

This grant is primarily basic and preclinical; it may not offer direct benefits to any individual participant during the grant period.

What this research studies

As people age, their blood vessels often don’t work as well, which can raise the risk of heart and brain diseases. This grant will look at how CSE and hydrogen sulfide signaling influence endothelial cells and vascular remodeling in aging, aiming to uncover new molecular mechanisms. The work uses laboratory studies with aging-related models to understand how reduced CSE/H2S might lower nitric oxide availability and worsen vascular function over time. The team plans to use two specific aims to identify pathways and test how changes in CSE/H2S affect aging blood vessels, with the goal of generating data for future, larger grants.

Why it matters

Potential benefit: If successful, this research could reveal targets to preserve vascular health as people age, potentially reducing cardiovascular and cognitive risks.

How similar studies have gone: Previous studies in vascular aging have shown that signaling molecules like hydrogen sulfide influence vessel function, supporting the potential of this approach.

Where this research is happening

  • Louisiana State Univ Hsc Shreveport
    Shreveport, United States
    Active

Researchers

  • Principal investigator: Kolluru, Gopi K — Louisiana State Univ Hsc Shreveport
  • Study coordinator: Kolluru, Gopi K

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.